Cellular and molecular neurobiology, Vol. 22, No. 5-6. (December 2002), pp. 797-804.
International journal of immunopharmacology, Vol. 21, No. 10. (October 1999), pp. 631-646.
Journal of neuroimmunology, Vol. 170, No. 1-2. (30 December 2005), pp. 134-140.
Journal of neuroimmunology, Vol. 196, No. 1-2. (30 May 2008), pp. 173-180.
Biol Psychiatry (6 January 2007)
Mol Psychiatry, Vol. 7 Suppl 1 (2002)
Int Clin Psychopharmacol, Vol. 22, No. 2. (March 2007), pp. 107-115.
Current Medical Research and Opinion, Vol. 23, No. 7. (July 2007), pp. 1605-1614.
J Clin Psychiatry, Vol. 67, No. 12. (December 2006), pp. 1836-1855.
Current Medical Research and Opinion, Vol. 23, No. 6. (June 2007), pp. 1303-1318.
by
Pigott, A
Teresa,
Prakash,
Apurva,
Arnold, M
Lesley,
Aaronson, T
Scott,
Mallinckrodt, H
Craig,
Wohlreich, M
Madelaine
Eur J Health Econ, Vol. 6, No. 4. (December 2005), pp. 317-321.
Pharmacoeconomics, Vol. 23, No. 2. (2005), pp. 155-167.
Biol Psychiatry (21 June 2007)
Clin Drug Investig, Vol. 27, No. 7. (2007), pp. 481-492.
Arch Gen Psychiatry, Vol. 62, No. 8. (August 2005), pp. 868-875.
J Affect Disord, Vol. 84, No. 1. (January 2005), pp. 1-13.
Clinical Therapeutics, Vol. 27, No. 1. (January 2005), pp. 111-124.
Cochrane Database Syst Rev, No. 2. (2000)
International Journal of Clinical Practice, Vol. 61, No. 4. (April 2007), pp. 702-710.
Journal of Clinical Pharmacy & Therapeutics, Vol. 32, No. 4. (August 2007), pp. 353-363.
Int J Neuropsychopharmacol (19 December 2005), pp. 1-12.
J Manag Care Pharm, Vol. 13, No. 6. (g 2007), pp. 8-18.
Ann Intern Med, Vol. 143, No. 6. (20 September 2005), pp. 415-426.
Int Clin Psychopharmacol, Vol. 19, No. 5. (September 2004), pp. 305-310.
Seishin Shinkeigaku Zasshi, Vol. 106, No. 10. (2004), pp. 1203-1217.
Cochrane Database Syst Rev, No. 3. (2007)
Current Medical Research and Opinion, Vol. 23, No. 2. (February 2007), pp. 251-258.
Cochrane Database Syst Rev, No. 3. (2007)
Manag Care, Vol. 13, No. 6 Suppl Depression. (June 2004), pp. 25-33.
Clinical Therapeutics, Vol. 27, No. 4. (April 2005), pp. 486-496.
J Subst Abuse Treat, Vol. 27, No. 4. (December 2004), pp. 307-312.
Psychol Aging, Vol. 18, No. 4. (December 2003), pp. 844-850.
(07 November 2005)
Am Fam Physician, Vol. 59, No. 8. (15 April 1999)
BMJ, Vol. 316, No. 7127. (24 January 1998), pp. 244-245.
Psychoneuroendocrinology, Vol. 18, No. 3. (1993), pp. 219-239.
Dev Psychol, Vol. 35, No. 4. (July 1999), pp. 926-939.
J Anxiety Disord, Vol. 18, No. 5. (2004), pp. 573-585.
Cost Effectiveness and Resource Allocation, Vol. 4 (23 October 2006), 18.
Annals of the New York Academy of Sciences, Vol. 1021, No. 1. (2004), pp. 143-147.
Arch Gen Psychiatry, Vol. 63, No. 12. (December 2006), pp. 1337-1344.
by CH
Kellner, RG
Knapp, G
Petrides, TA
Rummans, MM
Husain, K
Rasmussen, M
Mueller, HJ
Bernstein, K
O'Connor, G
Smith, M
Biggs, SH
Bailine, C
Malur, E
Yim, S
McClintock, S
Sampson, M
Fink
Science (5 July 2007), 1144400.
Acta Neurologica Scandinavica, Vol. 113, No. 1. (January 2006), pp. 1-8.
Frontiers in Neuroendocrinology, Vol. 26, No. 3-4. ( 2005), pp. 163-174.
Neurol Clin, Vol. 24, No. 3. (August 2006), pp. 441-460.
Curr Opin Psychiatry, Vol. 19, No. 3. (May 2006), pp. 294-298.
Am J Psychiatry, Vol. 164, No. 7. (1 July 2007), 1118.
Biol Psychiatry, Vol. 47, No. 3. (1 February 2000), pp. 200-209.
Biological Psychiatry, Vol. 57, No. 1. (1 January 2005), pp. 21-26.
Curr Opin Psychiatry, Vol. 20, No. 1. (January 2007), pp. 1-7.